235 related articles for article (PubMed ID: 29355304)
1. Computationally Assessing the Bioactivation of Drugs by N-Dealkylation.
Dang NL; Hughes TB; Miller GP; Swamidass SJ
Chem Res Toxicol; 2018 Feb; 31(2):68-80. PubMed ID: 29355304
[TBL] [Abstract][Full Text] [Related]
2. Modeling the Bioactivation and Subsequent Reactivity of Drugs.
Hughes TB; Flynn N; Dang NL; Swamidass SJ
Chem Res Toxicol; 2021 Feb; 34(2):584-600. PubMed ID: 33496184
[TBL] [Abstract][Full Text] [Related]
3. Regiochemistry and enantioselectivity in the oxidative N-dealkylation of verapamil.
Nelson WL; Olsen LD
Drug Metab Dispos; 1988; 16(6):834-41. PubMed ID: 2907462
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive kinetic and modeling analyses revealed CYP2C9 and 3A4 determine terbinafine metabolic clearance and bioactivation.
Barnette DA; Davis MA; Flynn N; Pidugu AS; Swamidass SJ; Miller GP
Biochem Pharmacol; 2019 Dec; 170():113661. PubMed ID: 31605674
[TBL] [Abstract][Full Text] [Related]
5. Investigation of Fenebrutinib Metabolism and Bioactivation Using MS
Alsibaee AM; Aljohar HI; Attwa MW; Abdelhameed AS; Kadi AA
Molecules; 2023 May; 28(10):. PubMed ID: 37241965
[TBL] [Abstract][Full Text] [Related]
6. Identification of an N-methyl-4-phenylpyridinium-like metabolite of the antidiarrheal agent loperamide in human liver microsomes: underlying reason(s) for the lack of neurotoxicity despite the bioactivation event.
Kalgutkar AS; Nguyen HT
Drug Metab Dispos; 2004 Sep; 32(9):943-52. PubMed ID: 15319335
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics reveals the formation of aldehydes and iminium in gefitinib metabolism.
Liu X; Lu Y; Guan X; Dong B; Chavan H; Wang J; Zhang Y; Krishnamurthy P; Li F
Biochem Pharmacol; 2015 Sep; 97(1):111-21. PubMed ID: 26212543
[TBL] [Abstract][Full Text] [Related]
8. Detoxication versus Bioactivation Pathways of Lapatinib In Vitro: UGT1A1 Catalyzes the Hepatic Glucuronidation of Debenzylated Lapatinib.
Nardone-White DT; Bissada JE; Abouda AA; Jackson KD
Drug Metab Dispos; 2021 Mar; 49(3):233-244. PubMed ID: 33376146
[No Abstract] [Full Text] [Related]
9. Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions.
Prakash C; Kamel A; Cui D; Whalen RD; Miceli JJ; Tweedie D
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):35S-42S. PubMed ID: 10771452
[TBL] [Abstract][Full Text] [Related]
10. Thiolactone sulfoxides as new reactive metabolites acting as bis-electrophiles: implication in clopidogrel and prasugrel bioactivation.
Dansette PM; Levent D; Hessani A; Bertho G; Mansuy D
Chem Res Toxicol; 2013 May; 26(5):794-802. PubMed ID: 23527615
[TBL] [Abstract][Full Text] [Related]
11. Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam.
Barnette DA; Schleiff MA; Osborn LR; Flynn N; Matlock M; Swamidass SJ; Miller GP
Toxicology; 2020 Jul; 440():152478. PubMed ID: 32437779
[TBL] [Abstract][Full Text] [Related]
12. Identification of primary and sequential bioactivation pathways of carbamazepine in human liver microsomes using liquid chromatography/tandem mass spectrometry.
Bu HZ; Zhao P; Dalvie DK; Pool WF
Rapid Commun Mass Spectrom; 2007; 21(20):3317-22. PubMed ID: 17879390
[TBL] [Abstract][Full Text] [Related]
13. Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network.
Hughes TB; Dang NL; Miller GP; Swamidass SJ
ACS Cent Sci; 2016 Aug; 2(8):529-37. PubMed ID: 27610414
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK
Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of tiaramide in vitro. I. Oxidative metabolism of tiaramide by human and rat liver microsomes.
Iwasaki K; Noguchi H; Kamataki T; Kato R
Xenobiotica; 1982 Apr; 12(4):221-6. PubMed ID: 7113258
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of atropaldehyde, a felbamate metabolite in human liver tissue in vitro.
Kapetanovic IM; Torchin CD; Strong JM; Yonekawa WD; Lu C; Li AP; Dieckhaus CM; Santos WL; Macdonald TL; Sofia RD; Kupferberg HJ
Chem Biol Interact; 2002 Nov; 142(1-2):119-34. PubMed ID: 12399159
[TBL] [Abstract][Full Text] [Related]
17. Drugs that inhibit oxidation reactions catalyzed by aldehyde oxidase do not inhibit the reductive metabolism of ziprasidone to its major metabolite, S-methyldihydroziprasidone: an in vitro study.
Obach RS; Walsky RL
J Clin Psychopharmacol; 2005 Dec; 25(6):605-8. PubMed ID: 16282848
[TBL] [Abstract][Full Text] [Related]
18. Predictability of the in vivo metabolism of verapamil from in vitro data: contribution of individual metabolic pathways and stereoselective aspects.
Kroemer HK; Echizen H; Heidemann H; Eichelbaum M
J Pharmacol Exp Ther; 1992 Mar; 260(3):1052-7. PubMed ID: 1545377
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach.
Abdelhameed AS; Attwa MW; Kadi AA
Drug Des Devel Ther; 2020; 14():5259-5273. PubMed ID: 33299299
[TBL] [Abstract][Full Text] [Related]
20. Identification of human liver cytochrome P450 enzymes involved in biotransformation of vicriviroc, a CCR5 receptor antagonist.
Ghosal A; Ramanathan R; Yuan Y; Hapangama N; Chowdhury SK; Kishnani NS; Alton KB
Drug Metab Dispos; 2007 Dec; 35(12):2186-95. PubMed ID: 17827338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
